What causes vhd in rabbits

What It Is

Viral Hemorrhagic Disease (VHD) is a fatal infection affecting rabbits caused by the rabbit hemorrhagic disease virus (RHDV), a non-enveloped RNA virus belonging to the Caliciviridae family. The disease manifests through sudden onset illness characterized by high fever, internal bleeding, organ failure, and rapid death in 24-72 hours after symptom appearance. VHD primarily affects European rabbits and certain domestic rabbit breeds, with some wild rabbit species showing more resistance to infection. The condition has become one of the most significant threats to both wild and domestic rabbit populations globally since its emergence.

The history of VHD begins in 1984 when the disease appeared in domestic rabbit farms in China, causing massive economic losses to the rabbit farming industry with mortality rates exceeding 80%. By 1989, the disease had spread to Europe through infected rabbit meat and hides, devastating rabbit populations in Spain, Italy, and France within two years. The World Organization for Animal Health recognized VHD as a reportable disease due to its significant economic and ecological impacts on wild rabbit populations. In 2010, a new and more aggressive variant called RHDV2 emerged, which proved capable of infecting younger rabbits and previously resistant species that showed immunity to the original virus strain.

VHD exhibits distinct clinical presentation patterns depending on the virus strain and rabbit age at infection, with acute form causing sudden death without preceding symptoms, subacute form showing 24-48 hours of illness before death, and chronic form affecting some rabbits with longer survival periods. Domestic rabbit breeds show varying susceptibility, with Angora and Angora crosses demonstrating greater resistance than Lop or Rex breeds. Wild European rabbits experience near-total mortality when first exposed to RHDV, though some populations have gradually developed natural genetic resistance over successive generations. The original RHDV strain caused highest mortality in rabbits 8-12 weeks old, while RHDV2 affects rabbits as young as 2-4 weeks old.

How It Works

The RHDV virus infects rabbits through inhalation of contaminated aerosol particles, ingestion of contaminated food or water, or through breaks in the skin and mucous membranes. Once internalized, the virus replicates rapidly in the intestinal tract and epithelial cells before spreading to the liver, spleen, and other organs within 24-48 hours of infection. The virus triggers a massive inflammatory response that causes hemorrhage (internal bleeding) throughout the body, organ failure, and death from septic shock and multi-organ dysfunction. The incubation period typically lasts 1-3 days, with most infected rabbits showing no clinical signs until acute collapse occurs.

In real-world situations, rabbit farmers experienced devastating losses exemplified by the 1989 Spanish rabbit epidemic where a single infected rabbit introduced to a breeding facility killed over 10,000 rabbits within four weeks through direct contact transmission. The virus spreads efficiently through rabbit-to-rabbit contact, contaminated food bowls, bedding, equipment, and even through the hands of handlers who touch infected rabbits and then touch healthy rabbits. Insects including fleas, lice, and flies can mechanically carry viral particles from dead rabbits to living rabbits, enabling transmission even when direct contact is prevented. In Australia, researchers intentionally introduced RHDV to control invasive European rabbit populations, successfully reducing rabbit numbers by 70-90% across affected regions.

The practical transmission sequence in domestic settings typically involves: introduction of virus through contaminated hay, vegetables, or equipment from an outside source; rapid spread through direct contact between rabbits in the same enclosure or room; mechanical spread via insect vectors if rabbits are housed outdoors; and complete loss of the rabbit herd within 5-14 days if multiple animals are affected. Vaccination protocols using inactivated RHDV vaccines can prevent the disease with 85-95% effectiveness when administered before exposure. However, vaccination does not protect against all RHDV2 variants, necessitating dual vaccination against both RHDV1 and RHDV2 strains for complete protection. Post-exposure prophylaxis (treatment of exposed but uninfected rabbits) proves ineffective, making prevention through vaccination the only reliable control strategy.

Why It Matters

VHD poses a critical threat to wild rabbit populations in many ecosystems, affecting European rabbit populations estimated in the billions that serve as prey species for lynx, foxes, golden eagles, and other predators dependent on rabbits for survival. The disease caused population declines of 50-80% in European rabbit populations during the 1989-1995 period following initial introduction, with long-term conservation impacts extending decades. In Australia and New Zealand, rabbit populations exploded to 200-600 million animals before RHDV introduction, causing agricultural damage estimated at $600 million annually; RHDV reduced populations by 70-90%, recovering grassland ecosystems and saving millions in agricultural losses. Endangered predators including Iberian lynx, Spanish imperial eagles, and Mediterranean monk seals depend critically on rabbit populations, making VHD control essential for their survival.

For domestic rabbit industry stakeholders worldwide, VHD represents the most economically significant disease affecting rabbit farming operations with estimated annual losses exceeding $50 million globally before widespread vaccination adoption. Pet rabbit owners face devastating losses when exposed to RHDV, with indoor rabbits suddenly developing fatal illness if exposed to the virus through contaminated hay, vegetables, or visitor contact. Commercial rabbit farms implementing strict biosecurity protocols and vaccination programs can prevent VHD losses entirely, but small breeders and backyard rabbit owners frequently experience total herd loss from single viral exposures. The emotional and economic impact on families who lose beloved pet rabbits to RHDV reinforces the importance of universal vaccination recommendations for all domestic rabbits.

Future developments in VHD management include development of live attenuated vaccines providing longer-lasting immunity compared to current inactivated vaccines, research into genetic selection for naturally resistant rabbit populations, and monitoring of emerging viral variants. Scientists are investigating probiotic and herbal interventions that may boost rabbit immune function against VHD, with preliminary results showing promise in reducing disease severity in experimentally infected rabbits. Epidemiological surveillance programs tracking RHDV prevalence in wild populations are improving, enabling early detection of new variant emergence and informing vaccination strategies. International cooperation through organizations like the World Organization for Animal Health is improving disease reporting and coordinating vaccination campaigns to prevent future pandemics affecting wild and domestic rabbit populations.

Common Misconceptions

A widespread misconception holds that VHD can infect humans or other animal species like cats and dogs, when in fact RHDV is species-specific and affects only rabbits and hares from the family Leporidae. People sometimes avoid handling rabbits or dispose of infected rabbits improperly due to false concerns about human infection, creating unnecessary anxiety and improper biosecurity practices. Scientific studies have definitively proven that humans cannot contract VHD, and other domesticated animals including guinea pigs, hamsters, and ferrets cannot be infected by the virus. Healthcare authorities and veterinary organizations worldwide confirm that human contact with infected rabbit tissues poses zero risk of viral transmission.

Another common myth suggests that infected rabbits can recover and develop immunity to VHD, when clinical data shows that once clinical signs appear, mortality approaches 100% with essentially no recovery cases reported in veterinary literature. Some rabbit owners mistakenly believe their rabbits survived RHDV infection because they recovered after initial illness, when in reality these cases represent other diseases with similar symptom presentation or misdiagnosis. Recovered rabbits that were previously exposed but did not develop clinical disease do develop antibodies and immunity, but this distinction is often confused with recovery from active infection. Early euthanasia of clinically affected rabbits is the most humane option since recovery is not possible.

People often incorrectly assume that indoor pet rabbits are completely protected from VHD and do not require vaccination, when in fact indoor rabbits can contract the virus through contaminated hay, vegetables, visitor clothing, or insect vectors brought indoors. Historical cases document indoor rabbits contracting VHD after their owners purchased contaminated hay from feed stores or brought wildflowers or garden vegetables containing virus particles into the home. Veterinary organizations including the American Rabbit Breeders Association and British Rabbit Council recommend vaccination for all pet rabbits regardless of housing, as the virus can survive for months on surfaces and is not reliably eliminated by typical home sanitization. The low vaccination rates among pet rabbit owners (estimated at 20-30% in many countries) represents a major misconception about disease risk and preventive medicine necessity.